CUSIP 92532F100COMVRTXQ4 2025
25 filings · latest Feb 12, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Capital World Investors | 25.51M | $11.57B |
| 2 | Vanguard Group Inc | 24.11M | $10.93B |
| 3 | Blackrock, Inc. | 23.75M | $10.77B |
| 4 | Capital Research Global Investors | 17.32M | $7.85B |
| 5 | State Street Corp | 11.69M | $5.30B |
| 6 | Jpmorgan Chase & Co | 6.04M | $2.74B |
| 7 | Geode Capital Management, LLC | 5.98M | $2.70B |
| 8 | Capital International Investors | 4.73M | $2.15B |
| 9 |
| 4 | Feb 12, 2025 | Fmr LLC | 13G/A | 3.6% | 9.22M | SEC |
| 5 | Apr 10, 2024 | Capital World Investors | 13G/A | 10.0% | 25.90M | SEC |
| 6 | Feb 13, 2024 | Vanguard Group Inc | 13G/A | 8.7% | 22.28M | SEC |
| 7 | Feb 9, 2024 | Capital World Investors | 13G/A | 8.6% | 22.08M | SEC |
| 8 | Feb 9, 2024 | Fmr LLC | 13G/A | 5.0% | — | SEC |
| 9 | Jan 25, 2024 | Blackrock Inc. | 13G | 8.5% | 21.88M | SEC |
| 10 | Feb 13, 2023 | Capital World Investors | 13G | 5.0% | 12.94M | SEC |
See the full Schedule 13D/13G history for Vertex Pharmaceuticals Inc.
Unlock full history| Alliancebernstein L.P. |
| 4.50M |
| $2.04B |
| 10 | Loomis Sayles & Co L P | 4.03M | $1.83B |